Complement Fixation Test: An Update of an Old Method for Diagnosis of Bullous Pemphigoid.

The complement fixation test (CFT) is a method traditionally used for diagnosis of gestational pemphigoid. Its performance in diagnosis of bullous pemphigoid (BP) has not been investigated in a large patient cohort. The aim of this single-centre, retrospective, serological case-control study of 300 patients with BP and 136 control patients was to analyse its operating characteristics. CFT was found to have a sensitivity of 71.7% and a specificity of 100%. Furthermore, CFT diagnosed 20 of 46 patients with BP (43.5%) who were negative for both BP180 and BP230 enzyme-linked immunoassays (ELISAs), 31 of 66 patients (47.0%) who were negative for indirect immunofluorescence of the oesophagus, 5 of 14 patients (35.7%) who were serologically negative for all investigated serological assays, and 7 of 18 patients (38.9%) in whom direct immunofluorescence was negative. Combination of CFT with all other serological assays resulted in a sensitivity of 95.3%. In conclusion, CFT is suitable for the diagnosis of BP, and can help to diagnose serologically challenging cases.

[1]  E. Alpsoy,et al.  Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid , 2015, Archives of Dermatological Research.

[2]  K. Tasanen,et al.  Gestational pemphigoid , 2014, Orphanet Journal of Rare Diseases.

[3]  H. Trau,et al.  Diagnosis and classification of autoimmune blistering diseases. , 2014, Autoimmunity reviews.

[4]  K. Peris,et al.  Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid. , 2013, Journal of the American Academy of Dermatology.

[5]  F. Antonicelli,et al.  Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients. , 2011, Archives of dermatology.

[6]  Z. Randriamanantany,et al.  Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid. , 2011, Archives of dermatology.

[7]  E. Bröcker,et al.  Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany , 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[8]  D. Zillikens,et al.  Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence. , 1999, Journal of the American Academy of Dermatology.

[9]  P. Fabbri,et al.  [The so-called herpes gestationis factor in bullous pemphigoid]. , 1990, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[10]  J. Bonnetblanc,et al.  Immunoblot analysis of IgG subclasses of circulating antibodies in bullous pemphigoid. , 1990, Clinical immunology and immunopathology.

[11]  T. Nishikawa,et al.  IgG subclasses of intercellular and basement membrane zone antibodies: the relationship to the capability of complement fixation. , 1989, The Journal of investigative dermatology.

[12]  K. Botzenhart,et al.  Brucellosis: serological methods compared , 1985, Journal of Hygiene.

[13]  T. Nishikawa,et al.  CORRELATION BETWEEN COMPLEMENT‐FIXING PEMPHIGOID ANTIBODY TITRES AND DISEASE ACTIVITY , 1980, The Journal of dermatology.

[14]  M. Meurer,et al.  The complement system in bullous pemphigoid. VI. C3 fixing activity in the absence of detectable antibody. , 1979, Clinical immunology and immunopathology.

[15]  S. Katz,et al.  Herpes gestationis. Immunopathology and characterization of the HG factor. , 1976, The Journal of clinical investigation.

[16]  R. Jordon,et al.  The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". , 1976, The Journal of clinical investigation.

[17]  R. Jordon,et al.  The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. , 1975, The Journal of laboratory and clinical medicine.

[18]  T. Tomasi,et al.  Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid. , 1973, The Journal of clinical investigation.

[19]  A. Wassermann,et al.  Eine serodiagnostische Reaktion bei Syphilis , 1906 .

[20]  J. Carruthers,et al.  Herpes gestationis: studies on the binding characteristics, activity and pathogenetic significance of the complement-fixing factor. , 1978, Clinical and experimental immunology.